Evidence map›Paper›PMID 35463783›Full record

ArticleFrontiers in cardiovascular medicine2022

Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation.

Jinjing Li, Jieqiong Zhao, Yonghong Lei, Yan Chen, Miaomiao Cheng, Xiaoqing Wei, Jing Liu, Pengyun Liu, Ruirui Chen, Xiaoqing Yin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Cardiovascular Interventions in Patients With Active and Advanced Malignancy: An Updated Review.Journal of community hospital internal medicine perspectives · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Cardiac MRI assessment of anthracycline-induced cardiotoxicity.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jinjing LiDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Jieqiong ZhaoDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Yonghong LeiDepartment of Plastic Surgery, Chinese PLA General Hospital, Beijing, China.
Yan ChenDepartment of Cardiology, People's Hospital of Taishan, Taishan, China.
Miaomiao ChengDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Xiaoqing WeiDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Jing LiuDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Pengyun LiuDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Ruirui ChenDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Xiaoqing YinDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Lei ShangDepartment of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, China.
Xue LiDepartment of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In our clinical work, we found that cancer patients were susceptible to coronary atherosclerotic heart disease (CAD). However, less is known about the relationship between CAD and cancer. The present study aimed to identify the risk factors for CAD and cancer, as well as the relationship between CAD and cancer. Methods: In this retrospective study, 1600 patients between January 2012 and June 2019 were enrolled and divided into groups according to whether they had CAD or cancer. Single-factor and multivariate analysis methods were applied to examine the risk factors for CAD and cancer. Results: (1) Cancer prevalence was significantly higher in patients with CAD than in patients without CAD (47.2 vs. 20.9%). The prevalence of CAD in cancer and non-cancer patients was 78.9 and 52.4%, respectively. (2) Multivariable logistic regression showed that patients with cancer had a higher risk of developing CAD than non-cancer patients (OR: 2.024, 95% CI: 1.475 to 2.778, Conclusion: (1) We discovered that CAD was an independent risk factor for cancer and vice versa. (2) Digestive, respiratory and urogenital cancers were independent risk factors for CAD. (3) We created a formula for the prediction of cancer among CAD patients. (4) ALT, usually considered a risk factor, was proven to be a protective factor for cancer in this study.

Indexed as

ALTcancercoronary atherosclerosisprediction modelrisk factors

Identifiers

PMID35463783
PMCPMC9021452
OpenAlexW4226320213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.